mediwales review - spring 2009

M E D I W A L E S M A G A Z I N E S P R I N G 2 0 0 9F E A T U R I N G B I O W A L E S A N D A R A B H E A L T H

BioWales 2010Welsh bioscience goes global

Winning performers2009 MediWales Innovation Award winners

Arab HealthCompany Directory

ShowcasesUltrasound Technologies LtdDTR MedicalBoots Centre for Innovation

MEDIWALES IS SUPPORTED BY THE WELSH ASSEMBLY GOVERNMENT

REVIEW-Arab Health 10 11/1/10 11:11

The Spring Edition of the MediWalesReview focuses on three events, eachpromoting the products and expertisein the bioscience sectors in Wales:BioWales 2010, our own MediWalesInnovation Awards and the Arab HealthExhibition.

BioWales 17 - 18 March, The Vale Hotel, The Vale of Glamorgan

BioWales is one of the UK's largestBioscience conferences andbiopartnering events held outside ofLondon, and has been running for 8years. Once again it will be held at theVale Hotel near Cardiff, and speakerswill include the Nobel Prize winner,Professor Sir Martin Evans. Last year381 delegates attended includingcompanies and academics aiming tocreate new connections and seekinglicensing and business developmentsopportunities.

MediWales Annual Innovation Awards

Our biggest event yet, with over 160guests, MediWales members, awardwinners past and present and VIPguests.

These awards have become a landmarkevent for the Welsh Lifescience sector.The 4th Annual Awards ceremony washeld on 1st December, at the CardiffHilton, and celebrated the presentationof 6 Industry awards, and 3 newcategories for Innovation in the NHS.

Arab Health 25 - 28 January 2010 -Dubai International Convention andExhibition Centre, UAE. The WelshPavillion: Hall 7 B53.

The Arab Health exhibition is thepremier healthcare event for the MiddleEast. This event plays host to healthcaremanufacturers, wholesalers anddistributors. providing a valuable arenain which to meet with some of the mostimportant decision makers in the Arabworld. With rapid year-on-year growth,Arab Health now has over 2,500exhibitors from 65 countries includingover 100 stands from UK companies.

The show will attract over 50,000visitors over the four-day event.

Welsh Companies

Several companies will be exhibitingfrom Wales, including UltrasoundTechnologies, Roma Medical Aids,Chromogenex, and DTR Medical.

International Business Wales (IBW) isthe organiser of the Welsh Pavilion atArab Health. IBW is the internationaltrade and investment arm of the WelshAssembly Government. They act as adriving force in establishing alliancesbetween companies in Wales and theircounterparts overseas. IBW alsoactively encourages inward investmentfrom overseas companies looking toEurope and the UK as a preferredinternational business location.

Welsh Medical Technology

Wales has a long and distinguishedhistory of industrial innovation andachievement. We have around 330companies operating in the Welshbioscience sector, including healthtechnologies, whose combined turnoveris approximately £1.3bn per year, withthe sector employing around 15,000people. Wales has a strong businessbase, globally respected academicinstitutions, and world-renown sportingand cultural venues.

MediWales is the industry-ownedforum, established to service the lifescience organisations in Wales. Overthe last seven years, MediWales hasbecome the sector representative andcentral point of contact, influencingWelsh and UK sector developmentstrategies and providing active routesfor member companies to accessclinical and academic expertise. Part ofMediWales's role is to act as asignposting and business supportservice for its members. It is similarlyhappy to assist international contacts insourcing commercial and collaborativeresearch and development partners inWales.

MediWales is a founder member of Medilink UK, the network of regionalmedical technology organisations that represents the interests of around 3000organisations across the UK.

Rewards, Awards and PromotionContents

BioWales 4-7

MediWales Innovation Awards 10-13

Arab Health Special 15

Welsh Pavilion Directory 18-19

Showcases 20-22

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZTelephone: +44 (0)29 2047 3456Forum Manager: [email protected] Manager: [email protected] Coordinator: [email protected](Contact for editorial and advertising)

Web: www.mediwales.com

MediWales Chairman: Mr Greg Baily, Huntleigh

The MediWales Review is designed by Teamworks Design Consultants

M E M B E R


M E D I W A L E S R E V I E W S P R I N G 2 0 1 0 B I O W A L E S

4

The first BioWales conference heldin 2002 - a small, but ambitiousaffair - has grown into what is nowone of the largest bioscienceconference and biopartnering eventin the UK. Spanning two days,BioWales plays host to a range ofactivity: there are presentationsfrom world-renowned speakers, a

BioWales: thriving in adversity

brokerage session with one-to-onemeetings, workshops on dedicatedtopics, with a trade-show exhibitionrunning throughout.

This multi-faceted conferencestrives to be 'fit for purpose' and isreformatted year on year to reflectand adapt to the needs of industry.

This year's major change is theintroduction of workshops to theprogramme. Delegate feedbackindicated that companies want astronger interactive element to theconference, allowing them todiscuss topics that potentiallyunderpin their success in themarket.

BioWales 2010 comes armed with renewed vitality: despite therecession, current statistics show that the Bioscience sector inWales is thriving. Contributing over £1.3bn to the Welsh economy,with over 330 businesses involved, the industry employs more than15,000 people. This sector has a lot to shout about and BioWales isthe perfect flagship to showcase its successes.


5

Wales such as Flexible Support forBusiness (FS4B) and the Academicfor Business (A4B) programmes.Funding is also available throughFinance Wales and Excalibur. Thefinal workshop - 'Inward InvestmentOpportunities' - will give anoverview of the sector, highlightingthe skills and sector supportavailable to companies.

The organisers also responded todelegate feedback by restructuringthe brokerage sessions. These havebeen reconfigured to enable moreone-to-one sessions betweenorganisations, and also to ensurethat the right people talk to eachother. The Brokerage activity iscentral to the BioWales mix, runningthroughout the two days. It is also apart of the conference that has

exponentially grown year on year:2009's brokerage had over 350meetings, up from 225 the previousyear.

Coordinating this impressive set upis Dr Sharon Thomas, the WelshAssembly Government's Healthcareand Life Science Specialist at theDepartment of Economy andTransport. She described the new'accept and decline' system for thebrokerage event and why it is beingimplemented 'It all starts with aninitial call for interested parties totake part via online registration.'Those seeking brokerage meetingsare linked to Bio-partneringregistration through the EUEnterprise Europe Network (EEN).The EEN facilitates technologytransfer throughout the UK and

Companies also stated that gainingaccess to finance has becomeincreasingly difficult in currenteconomic times. In response tothese concerns, the WelshAssembly has created threeworkshops dedicated to funding andfinance. The first workshop - run bythe Assembly's Research andDevelopment Advisor, Lisa Wheatley- is titled 'Funding opportunitiesfrom the EU Framework FundingProgramme'. This session willadvise businesses on what FP7funding is available, how to access itand how to write successfulproposals. The second session,titled 'Finance' will be co-run byBrenig Preest from Excalibur Groupand Meurig Watts from the WelshAssembly Government. This sessionwill discuss funding opportunities in


B I O W A L E S

Europe, bringing together thoseseeking or offering technologyopportunities, as well assupporting access to European-wide research fundingframeworks. Sharon continued'Each organisation submits atechnology profile, which canconsist of an offer or request fortechnology, know-how orexpertise. All profiles then getentered into the online catalogue.Approximately two weeks beforethe conference all registrants areasked to view the catalogue andselect other organisations thatthey'd like to meet with. In thepast, once a request had beenmade for a meeting that would beautomatically entered into themeeting schedule, howeverfeedback from last year indicatedthat at times there was a miss-match between companies -something that we are keen to

avoid. This new 'accept or decline'system allows the requestedcompany to either accept or declinethe meeting depending on theirrequirements. This makes sure thatevery company only has a schedulethat is 100% worthwhile to them.'

Sharon's dedication to perfectingBioWales's brokerage process hasbeen catalysed due to the deals andcollaborations that have occurredsince the last conference. 'In justthe first six months alone, as aresult of the brokerage, licensingdeals have increased by 100%'Sharon continues, 'There has alsobeen a significant rise is R&Dapplications under collaborativegrants. The brokerage event is verysuccessful and these results showa genuine need and purpose for itto grow and continue.'

BioWales is fully supported by theWelsh Assembly Government, whocontracted MediWales to deliver the2010 speaker programme. Workingwith Sharon and her team,MediWales has devised an highprofile line up including sessions onthe following topics: translationalresearch; stem cells -industrialisation for drugdevelopment and therapy; point ofcare diagnostics; cancer genetics;and “futurewatch” - an introductionto what's hot and new in biosciencetoday. The headline session - stemcell research and regenrativemedicine - is currently very highprofile across the UK, but especiallyin Wales. The session alsoheadlines Stephen Minger, head ofresearch and development for celltechnologies at GE Healthcare andrecently featured on the BBCHorizon programme: ‘Fix Me’(November 09).

6


7

BioWales 2010 sessions will feature:! Translational Research – what is it?! Stem Cells – industrialisation for drug development and

therapy.! Point of care diagnostics.! Cancer Genetics.! Futurewatch – an introduction to what’s hot and new in

bioscience today.

Biopartnering Event at BioWales 2010Run by Enterprise Europe Network Wales and linked to the EU Enterprise Europe Network, the Biopartnering event provides a catalogue of high quality technology profiles and a base allowing one to one meetings to discuss partnering opportunities.

17th and 18th March 2010The Vale Hotel, Golf & Spa Resort, Hensol near Cardiff, UK*

Wales’ largest bioscience conference,exhibition and biopartnering event.

BioWales 2010

*Just 2 hours from London, 30 minutes from Cardiff International Airport with ample free parking.

BioWales 2010 introduces the Welsh bioscience sector to an international, commercial, academic and NHS audience.

BioWales features :! Presentations from innovative companies and academia! Face to face partnering meetings! Spotlight on bioscience exhibiting companies! Workshops! 2 days of networking opportunities

Speakers for stem cell session include:

• Stephen Minger, GE Healthcare• Nobel Prize winner, Professor Sir Martin Evans• Anthony H Davies, Geron Corporation

To make the most of BioWales 2010 register NOW at – www.biowalesevent.com

Tell us a little about the history ofBioWales? BioWales started as a small conferencein 2002, centred on bioscience researchin Wales, to allow academia andindustry professionals to network. Thisinitial conference had 170 delegatesand was a great success. The nextevent in 2004 attracted even moredelegates, and BioWales has grownyear on year.

What’s planned for BioWales 2010? BioWales 2010 will be our biggestconference to date. After listening tofeedback from last year, we haveintroduced new workshop sessionsover the two days. We have booked fullsized stands in a larger exhibition area,as we are anticipating a high number ofdelegates. We are also offering a technologybrokerage service on an accept/decline

basis. Last year the brokerage serviceproved very popular and generated over350 meetings.

Who is speaking at BioWales 2010?This year’s programme features amixture of UK and Internationalspeakers, including Sir Martin Evans,who specialises in knock-out genesand has inaugurated a new spin outcompany. He has done stem cell workwith key industry figures, includingSteve Dennet, Charlie Archer and thedental school at Cardiff University.

What does BioWales offer the WelshLifescience industry?BioWales is the biggest bioscienceconference in Wales. The conferenceprofiles internationally and locallyrenowned speakers, attracting a widerange of delegates from Wales, thewider healthcare and lifesciencecommunities from the UK and beyond.

This makes it an excellent opportunityfor high quality networking and profilesexciting new developments inlifesciences. What can Biowales 2010 offercompanies?It gives Welsh bioscientists the chanceto promote themselves and theirorganisations on an international stage.International companies in turn willhave exposure to the Welshorganisations, and develop anunderstanding of what Wales has tooffer. It will allow people from outsideof Wales the chance to gain access toWelsh academia and NHSprofessionals, as well as informationsuch as licensing, collaborationopportunities and FP7 funding.IBW are supporting the programme,giving Welsh companies theopportunity to access assistance andadvice on international trade.

Dr Sharon Thomas on BioWales 2010


Q Chip, a biopharmaceutical drug delivery company, is developing Q-Sphera™ a range of injectable sustained-release biosimilar and biotherapy products. Q-Sphera products are biocompatible microspheres containing active pharmaceutical ingredient (API), made using Q Chip's patented encapsulation platform the MicroPlant™ device.

The key advantages of the Q-Sphera format are:

! The microspheres are extremely monodispersed with a high encapsulation efficiency of API! It is API neutral! Fast and inexpensive drug development ! Low cost manufacturing for

biosimilars

Q Chip's lead biosimilar products are Q-Leuprolide (primary indication for prostate cancer) and Q-Octreotide (primary indication for acromegaly).

Q-Sphera is also highly enabling for the encapsulation of fragile proteins for bio-therapeutic use.

Oddfellows House, 19 Newport Rd, Cardiff, CF24 0AA, Wales (UK)

Tel: +44 (0) 29 2048 0180Email: [email protected]: www.q-chip.com


........Accessible Biotechnology and Consultancy Services

Gene Expression Analysis

DNA Sequencing Services

Illumina Technology

Affymetrix Technology

Cell Sorting & Flow

CONTACT DETAILS:For further information about our ISO accredited

services, please contact Dr Anna Hurley(CBS Manager) at [email protected], or visit us at www.cardiff.ac.uk/medic/CBS.

Cytometry

MesoScale Discovery

Protein Production

Proteomics & Biacore

Histology Services

!"#$%"&'(%&)*#(+"*,$-&.!)+/

!"#$ %&'($)'*+'$), -)(./) #$ 0#1())/#(2 -133'+1/'.#4) '(,563.#,#$-#03#('/78/)$)'/-"9 -15+#(#(2 .") ):0)/.#$) 1; -3#(#-#'($9 )(2#())/$ '(,0"7$#-'38$-#)(.#$.$8#(8.")8'003#-'.#1(81;8('(1.)-"(131278.18")'3."-'/)<8=>?80/14#,)$1001/.6(#.#)$ .1&1/@ '. .") -6..#(2 ),2) #(.)/;'-) +).&))(A(2#())/#(28B#15),#-'38%-#)(-)8'(,8-3#(#-'38,)3#4)/7<8%)/4#-)$8#(-36,)C

A5+),,),=3'$$ D +#1312#-'3 ;'-#3#.#)$8E 6(#F6) 10)(*'--)$$ 0/#(.#(2 3'+1/'.1/78G/14#$#1(8;1/8$-#)(.#$.$H)(2#())/$8.18&1/@8&#."(1(*$#3#-1(8+'$),85'.)/#'3$E--)$$8.18):0)/.#$)8#(8/")15)./#-'38.)-"(#F6)$!10*,1&(8'(,8+1..15*608;'+/#-'.#1(8;'-#3#.#)$I),#-'.),8'--)$$8.18+6$#()$$8JKI

!!!"#!$%#&$"$'"()*%$%+,&$-.,

012&3"456*,&7$4

I!J8L),#-'38M.,8$0)-#'3#$)$8#(80/14#,#(285),#-'380/1;)$$#1('3$8&#."8"#2"F6'3#.78#((14'.#4)8$#(23)*6$)8$.)/#3)8#($./65)(.$8."'.8,)3#4)/80'.#)(.8'(,-3#(#-'384'36)98-15+#(),8&#."8):-)0.#1('383)4)3$81;8$)/4#-)<

E$8'(8):0)/#)(-),85),#-'38,)4#-)85'(6;'-.6/)/8;1/85'(78$0)-#'3#.#)$9I!J8L),#-'38M.,8"'(,3)$8,)$#2(8N3)$8'(,8=A85'/@#(2$<

I!J8L),#-'38"'$8.&18O%P8=3'$$8Q8R-3'$$8ST9TTTU8-3)'(/115$8'(,8'(8):0)/#)(-),0/1,6-.#1(8'(,8F6'3#.78.)'5<8!")8;'-#3#.78-1(.'#($8$0)-#'3#$.8'$$)5+378'(,0'-@'2#(285'-"#()/78.18"'(,3)8'8&#,)8/'(2)81;85),#-'38,)4#-)$<

O(8',,#.#1(98.18VTT8I!J8L),#-'380/1,6-.$98.")8-150'(78-1(./'-.85'(6;'-.6/)$14)/8STT8$.)/#3)85),#-'38,)4#-)$8'(,8-6$.1580'-@$8;1/81.")/85),#-'38,)4#-)5'(6;'-.6/)/$<

!!!"/.01&/2'$-"'+1

W1/851/)8#(;1/5'.#1(81(8XYA>8'(,8#.$81;;)/#(2$)5'#382%3+456&%"+06"()71/84#$#.C8!!!"56&%"+06"()

8#&9#$"%#*$5(#*,&2":;$*$5(#&'(%&1"6-#56*,&9##(<*$5(#&*#4&=>:"%$5?"

!")8XYA>8-1($1/.#6598)$.'+3#$"),8#(8DTTQ986(#.)$8."/))8Z'3)$*+'$),8-)(./)$.18):031#.8)5)/2#(285#-/18'(,8('(1.)-"(1312#)$<8Z1/3,*-3'$$8/)$)'/-"8'(,0/1,6-.#1(8;'-#3#.#)$8-15+#()8.185)).8$0)-#'3#$),8-6$.15)/8/)F6#/)5)(.$8'(,,)4)3108$6--)$$;638'(,8-1$.*);;)-.#4)8$136.#1($8;1/8+6$#()$$)$83'/2)8'(,8$5'33<

%134#(2 -1503): '003#-'.#1( 0/1+3)5$"'$+))(' $./)(2."&#."#( )'-"1;8XYA>[$8."/))8;'-#3#.#)$C8=)(./)8;1/8>'(1?)'3."8'.8%&'($)'8\(#4)/$#.79M'$)/8L#-/15'-"#(#(28M#5#.),8'(,8I!J8L),#-'38M.,<

!!!"56&%"+06"()

@;%&3"AB"%?C

7*?"%356%(A*6-5#5#D75A5$"4 .737/&

MLM98'8%.8E$'0"*+'$),8-150'(7980/14#,)$8);;)-.#4)8'(,8)-1(15#-8$136.#1($'(,8$"1/.)($8.#5)*.1*5'/@).8;1/8()&80/1,6-.8#,)'$86$#(283'$)/85'(6;'-.6/#(2.)-"(#F6)$< MLM)4'36'.)$ ,)$#2( #,)'$ $&#;.37 '(,0/14#,)$ ' /'0#, /16.) .185'(6;'-.6/#(286$#(28#.$8&1/3,*-3'$$83'$)/8;'-#3#.#)$98&"#-"8#(-36,)C

A4'36'.#1(H0/11;*1;*-1(-)0.8./#'3$E003#-'.#1($8,)4)3105)(.$G/1.1.70#(281;8,)4#-)$%#(23)8'(,8$5'338+'.-"80/1,6-.#1(M'/2)8F6'(.#.785'-"#(#(28$)/4#-)$!)-"(#-'38-1($63.'(-7=133'+1/'.#1(8&#."81.")/8L>!8$)/4#-)0/14#,)/$8.18-/)'.)8'8-1503).)8,)$#2('(,85'(6;'-.6/)80'-@'2)

!!!"-$#&012'0+1$',2%2%6"'+1


M E D I W A L E S R E V I E W S P R I N G 2 0 1 0 A W A R D S

10

The Annual MediWales Innovation Awards, our chance to celebrate the

successes and advances of Welsh companies in the Bioscience sector.

The categories recognising industry success are Innovation; Export

Achievement; Start-up; Outstanding Growth; Partnership with the

NHS; and the Judges’ Award. For the first time, the 2009 Awards also

included three extra categories for NHS personnel, in order to

commend the achievements within the Welsh NHS.

The Innovation Award was won byFirefly Medical Ltd, for their Single UseVaginal Speculum called Puraspec. The winning entry, the PuraspecSpeculum, is the leading product in themarket for over 6 million procedures inthe UK every year. The product hasbeen designed to be considerablystronger than the competition, with abreak safe feature designed into the

MediWales Awards 2009

Innovation AwardWINNER: Firefly Medical Ltdwww.fireflymedical.co.ukPRIZE SPONSOR: Gambit Corporate Financewww.gambitcf.com

Start Up AwardWINNER: Firefly Medical Ltdwww.fireflymedical.co.ukPRIZE SPONSOR: Boots Centre for Innovationwww.bootsinnovation.com

Outstanding GrowthAwardWINNER: DTR Medical Ltdwww.dtrmedical.comPRIZE SPONSOR: Abel andImray Patent Attorneyswww.patentable.co.uk


11

handle to prevent breakages within thepatient. It is quicker to use and isergonomically designed.Firefly Medical Ltd was established todevelop medical products for the NHSand primary care customers, offeringselective sales of leading equipment,consumables and pharmaceuticals.They have an experienced externalsales team with strengths inoccupational health, primary care andsexual health. They are IS013485:2003accredited and have a pharmaceuticalwholesale dealer’s license. Firefly also won the Start Up Award,presented to a newly establishedcompany in the healthcare sector thatshow a promising future.Firefly Medical Ltd demonstratedpromising success within their first 18months. They’ve sold 3rd partyproducts through the development ofan excellent ‘Web shop’ integrated intoSage accounts. They have alsolaunched a catalogue and carried oute-mail marketing. They’ve recruited 2experienced external sales staff andtheir buyer has direct contacts andexperience in sourcing from all theleading medical suppliesmanufacturers. They quickly gainedtheir pharmaceutical license and ISO13485:2003 accreditation. Firefly havelaunched their own niche product

(Puraspec). Required by every G.P inthe U.K, this product has beenimmediately accepted onto the EnglishNHS Framework and is best in class,in a market for 1.8 Million speculumseach year. The Export Achievement Award waswon by The Magstim Company Ltd, forincreasing their total exports by over35.7%. Magstim identified new markets inUSA, China, Middle East and Japanand have established and maintainedexclusive distribution agreements withcompanies in these territories. Thecombined results from Brazil, Chinaand Middle East gave Magstim sales inthe first three quarters of calendar2009, which was more than double thatof the preceding year. Magstim provides the means forneuroscientists to work with thehuman brain in awake subjects bymanufacturing and supplying state-of-the-art clinical and researchinstruments. Magstim products coverthe fields of neurology,neurophysiology, psychiatry, cognitiveneuroscience as well as ENT,orthopaedic and neuro-surgery.Magstim maintains a strongcommitment to R&D and productimprovement. Collaborating withresearchers in British and European

major centres of expertise (as well asthose in North America and Japan)ensures that Magstim remainsinformed about clinical and medicaladvances, enabling the company todevelop products at the forefront oftechnology. Products are sold directly to hospitalsand clinics in the UK and Ireland, withother principal markets in Germany,France, Benelux, Japan, the Far Eastand the USA. Magstim enjoys a closeand effective relationship with itsspecialist distributors and providessignificant training and after salesservices. DTR Medical won the OutstandingGrowth Award, for consistent,sustainable and profitable growth inthe sector. Their entry demonstrated consecutivegrowth in sales over the past 14quarters, resulting in Q3 09 nowmatching total annual performance for2006. They have achieved this growthdue to their development strategy: toinnovate for the needs of single-usedisposables versus the traditionalrequirements for autoclaving. Theresult is the creation of four distinctcatalogues with the product linesexpanding from 66 to 440 in four years.Medical sales in 2008 showed 66%growth, and in 2009-10 growth

Export AchievementAwardWINNER: The MagstimCompany Ltdwww.magstim.comPRIZE SPONSOR: UDLwww.udl.co.uk

Partnership withNHS/Academia AwardWINNER: Invacare UKwww.invacare.co.ukPRIZE SPONSOR: CatalystVenture Partnerswww.catvp.com


12

M E D I W A L E S R E V I E W S P R I N G 2 0 1 0 A W A R D S

remains at over 50% p.a. DTR Medical provides medicalprofessionals with high quality single-use sterile disposables that deliverclinical value combined withexceptional levels of service. Thecompany has operated for four years,during which time it won over 400 UKand International customers and hasexpanded the product rangedramatically to meet new marketdemands. The range includes manynew sterile single-use surgicalinstruments for specialists includingENT, neurosurgery, vascular andgeneral surgery, and gynaecologicalprocedures. In addition the companysupplies a range of products for sterileservices including sterile pre-cutsilicone tubing.

The Partnership with theNHS/Academia Award went to InvacareLtd for their Homefill oxygen system. Invacare have worked with DolbyMedical the Scottish oxygen contractorand NHS Oxygen Management todevelop a patient trial for the InvacareHomefill oxygen filling system, whichallows the patient to fill ambulatoryoxygen cylinders and be supplied withoxygen via a concentrator at the sametime. The risk assessment, trialprotocol, and clinical / patient producttraining have been developed inpartnership. Invacare supply the UKhealthcare market and the NHS with arange of products which include beds,

mattresses, cushions, walking aids,bathing and hygiene, moving andhandling respiratory equipment.

The Judges’ Award went to NorgineLtd, for their outstanding growth. On a constant currency basis,Norgine’s product sales increased byjust over 10%. 2008 was thereforeNorgine’s 22nd consecutive year ofdouble digit growth.Founded in 1906,Norgine is a specialty pharmaceuticalcompany with an extensive pan-European presence. They focus onpharmaceutical products that addresssignificant unmet clinical need inareas such as gastroenterology,hepatology and pain management.Throughout their long history, theyhave sought to develop and markethigh quality, innovative products forthe benefit of both patients andphysicians. They are committed todeveloping products not only to treatlife-threatening conditions but,importantly, to improve the quality oflife for patients with a range of acuteand chronic illnesses. They have along standing tradition of buildingrelationships, based on the higheststandards, with patients, physicians,employees, partners and other keystakeholders.In the last fifteen years, they havefocused on expanding their pan-European infrastructure, and havemoved to strengthen the Research &

Development base of the company.They are committed to developingproducts not only to treat life-threatening conditions but,importantly, to improve the quality oflife for patients with a range of acuteand chronic illnesses.The NHS Innovation within the NHSAward went to Marilyn WilliamsRadiology Department of the AneurinBevan University Health Board. Marilyn Williams won the Innovationwithin the NHS Award for a newservice that’s introduced patient-focused booking for all Radiologypatients across Gwent. This servicehas provided the department with onewaiting list, reduced waiting times andone process for all appointments. Prior to the start of the project in 2008,radiology appointments were arrangedby different groups of staff in localdepartments with varying waitingtimes and different processes.The new service was to introducePatient Focused Booking for allRadiology Patients across Gwent, onewaiting list, reduce wait times andhave one process for all appointmentsand set up the Radiology BookingService.

Judge's AwardWINNER: Norgine Ltdwww.norgine.com

Innovation within the NHS AwardWINNER: Marilyn Williams,Radiology Department for AneurinBevan Health Boardwww.wales.nhs.uk/sitesplus/866PRIZE SPONSOR: Chapman MolonyPatent & Trade Mark Attorneyswww.chapmanmolony.com


13

The NHS Partnership withIndustry/Academia Award went to DrJane Lewis ( Podiatry department ofthe Cardiff and Vale UniversityHealthboard).The Podiatry Department - at Cardiffand Vale University Health Board -collaborated with HuntleighHealthcare in Cardiff in the productionof the Dopplex Ability, a device foridentifying peripheral arterial disease(PAD) – a prevalent but often miss-diagnosed disease. This deviceaddresses three needs: to improve theidentification of PAD, the quality ofreferrals, and improve cardiovascularmorbidity and mortality. The device works via the simultaneousinflation of blood pressure cuffs, whichobviates the need for the patient to berested and considerably reduces theassessment time. Consultationsregarding clinical need, patient needand equipment design between thePodiatry department and HuntleighHealthcare have been ongoingthroughout the development andtesting of the product. Key designinputs have been fed into the project todetermine ease of use, acceptabilityand reproducibility in a clinicalenvironment.The test takes approximately 5minutes - compared to the currentmethod that requires 15mins rest plus10-25 mins testing time.DopplexAbility gives greater patient comfort,

shorter appointment times andincreases patient through put. It alsoallows for earlier diagnosis andintervention for lifestyle changes,which can lead to treatment of riskfactors resulting in fewer inappropriatereferrals for costly vascularconsultations and duplex scanning.Another knock-on effect is thereduction in the number of hospitaladmissions and amputations with aderived reduction in the pressure onsurgery and intensive care capacitiesat vascular surgery departments;fewer premature deaths would beexpected.

The NHS Judges’ Award went to StuartJones, from Cwm Seren Hywel DdaHealth BoardThe Judges Award is presented to theentry which the judges feel bestdemonstrates the spirit of theinnovation Awards. Cwm Seren is an Acute PsychiatricUnit that provides inpatient mentalhealth services for WestCarmarthenshire and SouthCeredigion. Lack of understanding ofmental health services by the policeled to the following initiative: InitialPolice Learning & DevelopmentProgramme (IPLDP) of Dyfed PowysPolice (DPP)– Mental HealthPlacement in partnership with HywelDda Health Board (HDHB).Stuart is based at Cwm Seren, an

Acute Psychiatric Unit providinginpatient mental health services forWest Carmarthenshire and SouthCeredigion. He set up the prizewinning Initial Police Learning &Development Programme (IPLDP) toaddress the local police’s lack ofunderstanding of mental health issuesand services.Through the scheme, student policeofficers within Dyfed Powys Policeattended a six day placement with themental health services, learning aboutMental Health First Aid and engagingwith staff, patients, patient user groupsand professionals in the unit. Learningfirsthand the patients’ ownexperiences, the police have beenapplauded for a more positive attitudetowards them.

Student officers have a pre-arrangedtime table of 2 days learning aboutMental Health First Aid along with a 4day placement in the mental health unitcovered by their Base Command Unit.This enables the officers to engage withstaff, patients, patient user groups andprofessionals in mental health care. Itinvolves them in all aspects of mentalhealth provision and allows them firsthand access to patients’ experiencesand services provided by the Trust.

NHS Partnership withAcademia and Industry AwardWINNER: Dr Jane Lewis,Department of Podiatry, Cardiffand Vale University Health Boardwww.wales.nhs.uk/sitesplus/864PRIZE SPONSOR: Wynne-Jones, Laine & JamesLLPwww.wynne-jones.com

NHS Judge's AwardWINNER: Stuart Jones, CwmSeren - Hywel Dda Health Boardwww.wales.nhs.uk/sitesplus/862


Exopack Advanced Coatings, Wrexham Industrial Estate, Wrexham LL13 9UF

www.exopackadvancedcoatings.com

Our inspire™ portfolio is based on a proven record in the design and manufacture of high performance

materials for wound dressings, ostomy products,incise films and medical conductive films for use in

EKG, EEG and TENS.

Breathable Films

Skin Friendly Adhesiv

es

Conformable

Conductive Films

Bacterial Barriers

Inspired coatings froma global leader

When you need a partner who understands your requirements, explores the options and provides innovative solutions for demanding applications, look no further than Exopack Advanced Coatings.

Contact us on

+44 (0)1978 660 [email protected]

DATA and the BILL OF RIGHTS for Patients

If DATA from Star Trek were a patient in the NHS he would have RIGHTS, so why not other data?

RIGHT decisions require The RIGHT data, at the RIGHT time, from the RIGHT place, using the RIGHT collection method.

The National AIDC Centre for Wales (Automatic Identification and Data Capture) has been set up as a Knowledge Transfer Centre under the Academic Expertise for Business (A4B) scheme of WAG to help companies achieve just those aims.

The scheme is Pan-Wales based at the University of Glamorgan with representation in Swansea, Aberystwyth, and Wrexham to provide help to organisations wishing to adopt ANY of the AIDC technologies, which include:- linear and 2D bar codes, active and passive RFID, and biometrics. AIDC is an enabling technology with potential application areas in every aspect of business.

And the BILL, if you are a Welsh based organisation is nothing for up to 3 days consultation, and feasibility study.

Contact Hywel Williams on 01443-654542 or

[email protected] www.aidcwales.org or www.aidc.org


A R A B H E A L T H S E C T I O N 2 0 1 0

Arab HealthCompany Directory

ShowcasesUltrasound TechnologiesDTR MedicalBoots Centre for Innovation


Visit www.magstim.com for more information. T: +44 (0)1994 240798 E: [email protected]

20 years in the field


Go East

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZT/F: +44 29 2047 3456Email: [email protected]

[email protected]@[email protected]

Web: www.mediwales.com

Chairman: Mr Greg Baily, Huntleigh

International Business WalesWelsh Assembly Government Department for theEconomy and TransportTrafalgar House5 Fitzalan PlaceCardiff, Wales CF24 0EDTel: +44(0)2920 828 786Web: www.ibwales.com

Geraldine Newbery – Mission LeaderGeraldine is involved in international tradedevelopment activity in the Middle East and Africa.This primarily involves managing and leading keyoverseas trade fairs and missions to the region.Email: [email protected]

The Middle East’s leadinghealthcare exhibition andcongress is growing.Arab Health touches upon allaspects of the healthcareindustry in the Middle East.

Tens of thousands of medical professionals,government officials, wholesalers, dealersand distributors converge on the DubaiInternational Exhibition Centre every year forthe region’s main event for the healthcareindustry. With the addition of 20,000 sqm atthe Dubai International Exhibition Centre,Arab Health has, for the first time in severalyears, the opportunity to grow and become aneven bigger event.

International Business Wales has arrangedfor several Welsh firms to attend the ArabHealth Mission, allowing them the opportunityto network with bioscience and medicalprofessionals from all over the world. Withthousands of delegates and hundreds ofexhibitors, the Arab Health Mission willpromote Welsh Bioscience in an internationalarena, and publicise the positive work goingon in Wales.

Arab Health 25 – 28 January 2010 – DubaiInternational Convention and ExhibitionCentre, UAE. The Welsh Pavillion: Hall 7 B53

The Arab Health exhibition is the premierhealthcare event for the Middle East. Thisevent plays host to healthcare manufacturers,wholesalers and distributors. It provides theseprofessionals with an opportunity to meetwith some of the most important decision

makers in the Arab world. With rapid year-on-year growth, Arab Health now has over2,500 exhibitors from 65 countries includingover 100 stands from UK companies. Theshow will attract over 50,000 visitors over thefour-day event.

The Welsh Pavilion

Several companies will be exhibiting fromWales, including:

Chromogenex

DTR Medical

Roma Medical Aids Ltd

Ultrasound Technologies Ltd

International Business Wales (IBW) is the

organiser of the Welsh Pavilion at Arab

Health. IBW is the international trade and

investment arm of the Welsh Assembly

Government. They act as a driving force in

establishing alliances between companies in

Wales and their counterparts overseas. IBW

also actively encourages inward investment

from overseas companies looking to Europe

and the UK as a preferred international

business location.

The Arab Health section of this Review has

been produced in collaboration with IBW: it

includes a directory of companies visiting and

exhibiting at the exhibition, with more detailed

case studies on a selection of attending

companies.

M E M B E R

MediWales is supported by the Welsh Assembly Government

Lee Jennings - Vice President (Middle East)The International Business Wales office in Dubai isresponsible for trade and investment developmentthroughout the Middle East and North Africa. Theoffice has been in existence since March 2004 and ismanaged by Lee Jennings, who has over 25 yearsexperience of trade and business developmentcovering China, South East Asia, Southern Asia andmore recently, 8 years in the Middle East. Leemanages a network of business experts throughoutthe Arabian Gulf and is able to assist Welshcompanies with research, information and a widerange of contacts and advice.Mobile: +971 50 559 3668Email: [email protected]

A R A B H E A L T H - W A L E S P A V I L I O N D I R E C T O R Y


S H O W C A S E

18

Geraldine NewberyMission Leader, Middle East and AfricaWeb site: www.walestrade.comDescription: HALL 7, Stand B53

Lee JenningsTel: +971 50 559 3668Email: [email protected]

International Business Wales

Chromogenex

IBWTrafalgar HouseFitzalan PlaceCardiffWalesUKCF24 0EDTel: +44(0)2920 828 786Fax: +44 (0)2920 442 696Email:[email protected]: www.ibwales.com

International Business Wales is the Welsh AssemblyGovernment’s international trade and investment arm. Itforms part of the Department for the Economy andTransport and acts as the driving force in establishingalliances between companies in Wales and theircounterparts overseas, whilst actively seeking out inwardinvestment opportunities for client companies looking toEurope and the UK as a preferred international businesslocation.Geraldine is involved in international trade developmentactivity in the Middle East and Africa. This primarily involvesmanaging and leading key overseas trade fairs and missionsto the region.Geraldine and Lee will be on hand to assist the attendingcompanies during the duration of the exhibition.

Units 1&2 Heol RhosynDafen ParkLlanelli SA14 8QGTel: 01554 755444Fax: 01554 [email protected]

Chromogenex design, manufacture and service lasers and intenselight systems for the health and beauty market. Key products are:ilipo – a body shaping fat reducing device without the need for pain,needles or downtime.Chromolite/Phaser – intense pulse light for hair removal, skinrejuvenation and pigmentation.Regenlite – a pulse dye laser for vascular, acne and skinpigmentation. The company also sells consumables, service contracts and otherancillary goods. Chromogenex has established direct salesoperations in the UK, French and Canadian markets and makesfurther export sales via a comprehensive network of distributors.

Arab Health 25 – 28 January 2010 - Dubai International Convention and Exhibition Centre, UAE

The Welsh Pavilion: Hall 7 Stand B53

M E D I W A L E S R E V I E W S P R I N G 2 0 1 0

Peter McGuinessKevin Williams

Asia Scientific Supply

53 Ogwen DriveLakeside CardiffCF 23 6LJ Tel:- +44 (0)29200766676Fax :- :+44 (0)29200766676Email: [email protected]

Asia Scientific Supply Company is the corner stone for the export ofBritish products to Iraq where our partners Asia Scientific Bureauand Al-Hirse Company are dealing with the private and governmentsectors in the fields of medical, agriculture, scientific and oil.

Mission delegatesMuthaffar Ameen Behnam Kurukchi Pat Trigg


195


DTR

17 Clarion CourtEnterprise ParkSwanseaSA6 8RFTel: 01792 797910Fax: 01792 797955Email: [email protected]: www.dtrmedical.com

DTR Medical aim to provide medical professionals with high qualitysingle-use sterile disposables that deliver patient and clinical valuecombined with exceptional levels of service. The company hasoperated in this market for over three years, during which time itwon some 350 new customers.The range includes sterile single-use disposable surgicalinstruments and related theatre and clinic products, for specialitiesincluding ENT, neurosurgery, vascular and general surgery, andgynaecological procedures. In addition, the company supplies arange of products for sterile services.

AAnnddrreeww DDaavviiddssoonn Managing Director

Nick SeeAnn See

Roma Medical

Roma Medical Aids Ltd is recognised as one of the leading UKmanufacturers and suppliers of mobility, medical and rehabilitationequipment. The product range consists of manual wheelchairs, powerwheelchairs, electric scooters, walking aids, rollators, commodes,bathing aids, toileting aids, shower equipment and homecareequipment.At Arab Health, the latest range of Anti-Microbial Sanichairs will bedisplayed, which have been recently introduced with great successinto the UK hospital market. Incorporating many patented featuresand manufactured in the UK from the highest quality materials, theRomaChair has been developed with close co-operation with hospitalstaff, clinicians and Infection Control managers. Roma Medicalsobjectives for Arab Health are to build on existing contacts andestablish new contacts in the Gulf region. We look forward to meetingwith you at our stand.

Ultrasound

Ultrasound Technologies has a history of over 25 years in fetal andvascular doppler systems. We offer over 12 doppler models, fromsimple fetal audio units to those including fetal heart rate display.Vascular products are available with a choice of fine pencil probe orstandard vascular pocket units for routine vascular investigation andABPI testing.Fetal monitoring covers all antepartum and intrapartum applicationswith the fetatrack 310 and fetatrack 360, offering easy-to-use systemsfrom Ultrasound monitoring to continuous fetal pulse oximetry.All the units have been designed by Ultrasound Technologies and aremanufactured in the company’s ISO9000:2000/ ISO13485:2003certified factory in Caldicot, South Wales.Ultrasound Technologies’ products are sold in over 90 countriesworld-wide and supported by a team of distributors in each country.

Roma Medical Aids Ltd, York Road, Bridgend Industrial Estate, Bridgend, CF31 3TB. Tel. 01656 674488 Fax. 01656 674499 Web. www.romamedical.co.uk

Ultrasound Technologies LtdLodge WayPortskewettCaldicotNP26 5PSUKTel: +44 (0)1291 425425Fax: +44 (0)1291 427093email:[email protected]: www.doppler.co.uk

Stand contacts Simon DaltonManaging DirectorEmail: [email protected] John DaltonConsultantEmail: [email protected]


M E D I W A L E S R E V I E W S P R I N G 2 0 1 0 S H O W C A S E

20

Ultrasound Technologies designs andmanufactures complex medicalelectronic products from their designand manufacturing centre inCaldicot, South Wales. This includesa range of fetal and vascularDopplers as well as fetal monitorswhich they export internationallythrough a large network ofdistributors.

New Designs and products:

Using “soft” design techniquesUltrasound Technologies areintroducing a series of units that areaesthetically pleasing and friendly,reducing fear and stress to thepatient.

The first to be shown at Arab Health2010 is their newest product, theFetatrack DD250 which offerscontinuous fetal and vascular Dopplerin the small clinic, hospital or doctorsoffice.

Weighing under 2Kg the FetatrackDD250 is a truly portable unit. It willoperate from a mains supply or forover 30 hours from its built-inrechargable batteries.

The Fetatrack DD250 has all thenecessary facilities for accurateantenatal fetal assessment in onecost effective and compact unit.

With its full digital multipointautocorrelation the fetal heartdetection it provides is accurate andreliable with the display of fetal heartrate on a large easy to read LCDdisplay.

Simple to operate the DD250 isdesigned with one control that turnsthe unit on/off and adjusts thevolume.

Fetal heart records can be kept byusing the FetaTrace software that isavailable as a monitoring packagewith the option of a wide anglemonitoring transducer.

All Fetatrack products come with astandard 3 year warranty lowering thecost of ownership. With over 25 yearsof supplying fetal heart detectors andmonitors you can be assured that anyproblem your Fetatrack unit willencounter over its lifetime will be fixedquickly and reliably.

Evolutionary Design:

Ultrasound Technologies in a designcollaboration with their partnerFreeplay Energy of Cape Town recentlywon the ‘Index Award : Design ToImprove Life’ for the first ever selfpowered Doppler to be used indeveloping countries around theworld, where power is not available.

At the award ceremony in CopenhagenUnicef stated that they are a strongbeliever that this little Doppler willhelp to save millions of mothers andbabies across the world and we,

Ultrasound Technologies, are veryhappy to be a part of this fantasticproduct.For more information please visitwww.doppler.co.uk

Ultrasound Technologies Ltd

Ultrasound Technologies LtdLodge WayPortskewettCaldicot NP26 5PSUnited KingdomT: +44 (0) 1291 425425F: +44 (0) 1291 427093E: [email protected]


21

DTR Medical – the rapidly growingspecialist in sterile single-usesurgical instruments – is seeing asignificant rise in enquiries frommany parts of Europe, the MiddleEast, and beyond, underlying thegrowing need for highquality disposableequipment.

DTR Medical believesthere are several factorsinfluencing the increasein sales for sterile singleuse equipment. Firstly,single-use disposablesreduce the risk of cross-contamination.Complications like surgicalsite infections and extendedhospital stays are minimised,which lowers costs andreduces potential litigation.

Secondly, disposables rule outreprocessing – the need to cleanreusable instruments.Reprocessing is a difficult andtimely process, often leading todelayed patient throughput andraised costs from high manualhandling rates.

Another positive with single-usedisposables is that they don’t needconstant validation and repair, which isexpensive, and can disrupt theatreprocedures if reworking is delayed.

Lastly, there is the issue ofreplacement capital with reusableunits, as multiple sets are required tocope with high patient numbers. This iseven more expensive whenreprocessing is done away from theclinical location, which increases thecost over the funding estimates.

These cumulative cost-saving andpatient benefits are being noticed farand wide. During a recent internationalENT symposium in London – the 27thPolitzer Society – leading surgeons

from across Europe expressed interestin using DTR Medical’s single-useinstruments in their own clinicalpractise. Some delegates were so

committed to these potential benefits,that they placed orders during themeeting.

Single-use surgical instruments arenot designed to replace all re-usableitems, as they are most effective whenused selectively to resolve acombination of the above factors.Managers of sterilisation serviceswelcome the disposable items as theyhelp them to combat the issues facedby utilising re-usable instruments.

For instance, validating the sterility oflong lengths of tubing is oftenproblematic: DTR Medical eradicatesthis problem by supplying its rangeof pre-cut lengths of sterilesilicone tubing, which are nowbeing sold as far afield as NewZealand.

To help hospital efficiency,single-use disposableinstruments must be of aconsistently high quality, andbe readily available at alltimes. DTR Medical takesparticular care to ensurethat every instrumentmeets specification. Tokeep up with thedemands of their clients,the company iscontinually improvingand re-evaluating its

systems. They recentlychanged theirmethod ofmanufacturing aseries of medical

DTR Medical


instruments - the Frazier SuctionHandle Range – in order to allow forgreater flexibility and efficiency. Therange now includes two and four tip

fenestrations, and is used across mostsurgical specialities. This modificationto the manufacturing process hasenabled the potential for more lines ofproducts. A similar approach has beenused to produce a range of sterilesingle-use Tibbs Arterial Cannula,which are used in many vascularprocedures.

Growing international demand meansDTR Medical is looking forward to thefuture, and is creating newpartnerships with Welsh Universities todeliver major new lines, includingdevelopments in gynaecologicalsurgery.

DTR MedicalSwansea SA6 8RFT: +44 (0) 1792 797910F: +44 (0) 1792 797955E: [email protected]: www.dtrmedical


M E D I W A L E S R E V I E W S P R I N G 2 0 1 0

Maintain your Equilibrium: acalming solution for ‘stressed’consumers

Boots Equilibrium® is a foodsupplement which aims to help peoplemanage the pressures of modern life.It contains a unique patentedingredient, Lactium®, which canprovide calming support to help withthe stresses and strains of everydaylife. Lactium is a bio-protein isolatedfrom milk which has been studiedextensively for over ten years and hasrelaxing properties that reduce andregulate stress-related troublesnaturally.

Lactium is now available in the UK forthe first time in Boots Equilibrium. It isoffered in two different formats: aconvenient once-a-day capsule in 7 or14 day packs and a comforting hotchocolate drink.

Initial developmentsLactium was first developed byresearch scientists in the 1990s. It hasshown proven efficacy on humans in sixclinical studies using validatedbiological indicators and randomised,double-blind and placebo controlledprocedures.

The Boots Centre for Innovation (BCI)team was introduced to Lactium by aCheshire company, Fayrefield FoodTec,which specialises in providinginnovative food ingredients. FayrefieldFoodTec presented the BCI with anumber of novel ingredientopportunities that it believed could be

appropriate for new health andwellness products.

The BCI investigated the claims andscience behind all the opportunitiesand quickly established a technicalinterest in Lactium and its calmingproperties. It was a food-grade,patented product that represented abreakthrough in the field of nutrition.

Meeting a consumer needThe BCI had identified sleep, stress andenergy as a sector with a key unmethealthcare need and was looking forsolutions to address this market inresponse to customer demand.

The organisation spoke to expertson the mechanics of sleep and thelinks to everyday stresses causedby modern lives, and alsocommissioned research to identifythe products consumers are happyto use. This revealed a reluctanceto use traditional sleeping pillsand a preference for supplementsand drinks.

Consumers want tailoredsolutions for their individual needswhich will help them relax andunwind before bed and have an

uninterrupted night’s sleep. Thisincludes both quick fixes for temporaryproblems, such as to help them sleepwhen they have a cold, and solutionswhich deal with the root causes forlong term sufferers.

Lactium appeared to have considerablepotential in this market, provided thatsuitable product formulations could bedeveloped.

BCI’s role in the developmentBCI began by establishing Lactium’sscientific credibility. They then workedwith colleagues in the Boots healthcareteam to assess the commercialopportunity for Boots.

Having concluded that a potentialmarket existed, BCI introducedFayrefield FoodTec to the AllianceBoots product development team andthe businesses worked together to

Boots Centre for Innovation22

S H O W C A S E

develop product formulations usingLactium. Twenty months later, the twoproduct formats were launched toconsumers.

Gail Eastaugh, the BCI’s businessdevelopment manager, comments:“This is a great example of how theBCI can take external innovation whichis supported by thorough clinicalevidence and, using Boots’ expertise informulation, marketing and packaging,develop a winning product for ourcustomers.”

Steve Timms, sales and businessdevelopment director from FayrefieldFoodTec, said: “Developing theEquilibrium product and bringing it tomarket has been much easier than Ihad expected, with the team at BCIsupporting me every step of the way.They have a great deal of expertise,and without their support and the openapproach from BCI the whole processwould have been a lot tougher.”

The products were launched inSeptember 2009, and are selling well.Boots was so confident aboutEquilibrium with Lactium that theinitial launch was supported with a‘feel the difference or your moneyback’ guarantee on seven-day packs ofEquilibrium, allowing customers toexperience the benefits forthemselves.

Boots healthcare expert Gavin Staintonconcludes: “Boots Equilibrium withLactium offers anyone who feels undereveryday pressure an aid to deal withit. The expertise behind this productmakes it one of the most excitinglaunches this decade.”

Boots Centre for InnovationInstitute of Life ScienceUniversity of SwanseaSwansea SA2 8PPWales UKTel: +44 (0)1792 513 722Email: [email protected]: www.bootsinnovation.com


mediwales review - spring 2009

Documents

welsh companies

arab health exhibition

welsh bioscience

uk companies

e d i w

n e s p r i n g

alliancesbetween companies

welsh pavilion atarab